经导管二尖瓣置换术的最新进展。

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart International Pub Date : 2021-12-20 eCollection Date: 2021-01-01 DOI:10.17925/HI.2021.15.2.79

Tomoya T Hinohara, Michael J Reardon, Sachin S Goel

{"title":"经导管二尖瓣置换术的最新进展。","authors":"Tomoya T Hinohara, Michael J Reardon, Sachin S Goel","doi":"10.17925/HI.2021.15.2.79","DOIUrl":null,"url":null,"abstract":"Mitral regurgitation (MR) is the most prevalent valvular heart disease globally. Mitral valve surgery is the gold-standard treatment for MR. However, a significant portion of patients with mitral valve disease are at high or prohibitive surgical risk. Transcatheter mitral valve replacement (TMVR) has emerged as a potential treatment option for this vulnerable population. Numerous TMVR devices are currently being investigated, with early data demonstrating feasibility and efficacy of TMVR. In this article, we explore the unique challenges of designing a TMVR system and describe the TMVR systems under clinical evaluation.","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"15 2","pages":"79-83"},"PeriodicalIF":1.9000,"publicationDate":"2021-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524844/pdf/heart-int-15-79.pdf","citationCount":"2","resultStr":"{\"title\":\"Latest Advances in Transcatheter Mitral Valve Replacement.\",\"authors\":\"Tomoya T Hinohara, Michael J Reardon, Sachin S Goel\",\"doi\":\"10.17925/HI.2021.15.2.79\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Mitral regurgitation (MR) is the most prevalent valvular heart disease globally. Mitral valve surgery is the gold-standard treatment for MR. However, a significant portion of patients with mitral valve disease are at high or prohibitive surgical risk. Transcatheter mitral valve replacement (TMVR) has emerged as a potential treatment option for this vulnerable population. Numerous TMVR devices are currently being investigated, with early data demonstrating feasibility and efficacy of TMVR. In this article, we explore the unique challenges of designing a TMVR system and describe the TMVR systems under clinical evaluation.\",\"PeriodicalId\":12836,\"journal\":{\"name\":\"Heart International\",\"volume\":\"15 2\",\"pages\":\"79-83\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2021-12-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524844/pdf/heart-int-15-79.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heart International\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17925/HI.2021.15.2.79\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/HI.2021.15.2.79","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 2

摘要

二尖瓣反流(MR)是全球最常见的瓣膜性心脏病。二尖瓣手术是mr的金标准治疗方法，然而，很大一部分患有二尖瓣疾病的患者有很高的或禁止手术的风险。经导管二尖瓣置换术(TMVR)已成为这一易感人群的潜在治疗选择。许多TMVR设备目前正在研究中，早期数据证明了TMVR的可行性和有效性。在本文中，我们探讨了设计TMVR系统的独特挑战，并描述了TMVR系统的临床评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Latest Advances in Transcatheter Mitral Valve Replacement.

查看原文本刊更多论文

Latest Advances in Transcatheter Mitral Valve Replacement.

Mitral regurgitation (MR) is the most prevalent valvular heart disease globally. Mitral valve surgery is the gold-standard treatment for MR. However, a significant portion of patients with mitral valve disease are at high or prohibitive surgical risk. Transcatheter mitral valve replacement (TMVR) has emerged as a potential treatment option for this vulnerable population. Numerous TMVR devices are currently being investigated, with early data demonstrating feasibility and efficacy of TMVR. In this article, we explore the unique challenges of designing a TMVR system and describe the TMVR systems under clinical evaluation.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Heart International Medicine-Cardiology and Cardiovascular Medicine

CiteScore

0.90

自引率

0.00%

发文量

审稿时长

7 weeks